Adenosine

Category
nucleoside
Half-Life (t½)
IV: 0m
Formula
C10H13N5O4
Molecular Weight
267.24 g/mol
PubChem CID
60961
Aliases
Adenine riboside

Pharmacological Mechanism

Endogenous signalling nucleoside acting at four GPCR subtypes: A1 (cardiac slowing, inhibition of NE release), A2A (vasodilation, wakefulness suppression — caffeine's principal target), A2B, A3. Accumulates with neural activity and is the presumed somnogen driving sleep pressure. Extremely short plasma t½ (seconds) — deaminated to inosine by adenosine deaminase.

Half-Life & Elimination Curve (IV: 0m)

100%50%25%12.5%0%0h0×t½0m1×t½0m2×t½1m3×t½1m4×t½1m5×t½0×t½ (0h): 100% remaining (~0.286 mg/L)1×t½ (0m): 50% remaining (~0.143 mg/L)2×t½ (0m): 25% remaining (~71.4 µg/L)3×t½ (1m): 12.5% remaining (~35.7 µg/L)4×t½ (1m): 6.3% remaining (~17.9 µg/L)5×t½ (1m): 3.1% remaining (~8.93 µg/L)
Elimination (IV)
  • 0×t½0h100% (0.286 mg/L)
  • 1×t½0m50% (0.143 mg/L)
  • 2×t½0m25% (71.4 µg/L)
  • 3×t½1m12.5% (35.7 µg/L)
  • 4×t½1m6.3% (17.9 µg/L)
  • 5×t½1m3.1% (8.93 µg/L)
Elimination t½0m (IV)
Rate Constant (ke)248 h⁻¹
Est. Peak (Cmax)0.286 mg/L
Clearance (CL)5200 L/h
97% Washout (5×t½)1m

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References